Long-Acting Biologic with Transmucosal Transport Properties Shows Promise in Combating SARS-CoV-2 Virus Variants
by In response to the emergence of new SARS-CoV-2 virus variants that render current monoclonal antibodies ineffective, researchers have developed a potential solution. A team led …